MCM
CVS icon

Marathon Capital Management’s CVS Health CVS Stock Holding History

Marathon Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,913
Closed -$203K – 159
2023
Q3 		$203K Buy
+2,913
New +$206K 0.05% 139
2023
Q2 		– Sell
-3,235
Closed -$240K – 160
2023
Q1 		$240K Hold
3,235
– – 0.06% 135
2022
Q4 		$301K Buy
3,235
+55
+2% +$5.31K 0.08% 115
2022
Q3 		$303K Hold
3,180
– – 0.09% 118
2022
Q2 		$295K Buy
+3,180
New +$310K 0.1% 110
2022
Q1 		– Sell
-43,860
Closed -$4.53M – 114
2021
Q4 		$4.53M Sell
43,860
-9,025
-17% -$834K 1.06% 18
2021
Q3 		$4.49M Buy
52,885
+3,112
+6% +$261K 1.02% 16
2021
Q2 		$4.15M Sell
49,773
-108
-0.2% -$8.84K 0.96% 19
2021
Q1 		$3.75M Buy
49,881
+2,361
+5% +$172K 0.99% 22
2020
Q4 		$3.25M Sell
47,520
-932
-2% -$60.6K 0.96% 19
2020
Q3 		$2.83M Sell
48,452
-2,103
-4% -$131K 1.03% 16
2020
Q2 		$3.29M Buy
50,555
+1,141
+2% +$71.8K 1.26% 11
2020
Q1 		$2.93M Buy
49,414
+4,145
+9% +$277K 1.35% 8
2019
Q4 		$3.36M Buy
45,269
+325
+0.7% +$22.8K 1.14% 9
2019
Q3 		$2.83M Buy
44,944
+4,126
+10% +$244K 1.14% 9
2019
Q2 		$2.22M Buy
+40,818
New +$2.2M 0.91% 17

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marathon Capital Management's CVS Position: Q4 2023 in Review

Marathon Capital Management sold out of CVS Health (CVS) in Q4 2023, closing a stake of 2,913 shares — an estimated $203K sold.

Marathon Capital Management first reported a position in CVS in Q2 2019 and held it in 16 quarters. The position peaked at $4.53M in Q4 2021. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Marathon Capital Management reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Marathon Capital Management sold 2,913 CVS Health shares in Q4 2023, an estimated $203K.
  • Marathon Capital Management first reported a position in CVS Health in Q2 2019 and held it in 16 quarters.
  • Marathon Capital Management's CVS Health position peaked at $4.53M in Q4 2021.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Marathon Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.